Table 1.
Baseline characteristics of overall eligible subjects and transplant recipients
| Characteristic | Eligible subjects (n = 23) | HCV-viremic kidney transplant recipients (n = 8) |
|---|---|---|
| Age at time of consent, yr, mean (SD) | 56.2 (7.7) | 55.9 (9.4) |
| Female, n (%) | 10 (43.5) | 2 (25) |
| Race/ethnicity, n (%) | ||
| White, non-Hispanic | 19 (82.6) | 7 (87.5) |
| Hispanic | 3 (13.0) | 1 (12.5) |
| Black | 1 (4.4) | 0 |
| ESRD cause, n (%) | ||
| Diabetes/hypertension | 15 (65.2) | 3 (37.5) |
| IgA nephropathy | 3 (13.0) | 3 (37.5) |
| Polycystic kidney disease | 2 (8.7) | 1 (12.5) |
| Systemic lupus erythematosus | 1 (4.4) | 1 (12.5) |
| GPA | 1 (4.4) | 0 |
| Chronic reflux | 1 (4.4) | 0 |
| Blood type, n (%) | ||
| A | 12 (52.2) | 5 (62.5) |
| O | 8 (34.8) | 3 (37.5) |
| B | 4 (13.0) | 0 |
| Prior transplantation, n (%) | 1 (4.4) | 1 (12.5) |
| BMI, median (IQR) | 29.2 (26.6–31.8) | 29.9 (28.0–31.6) |
| History of diabetes, n (%) | 14 (60.9) | 4 (50) |
| Days on waitlist prior to consent, median (IQR) | 506 (340–657) | 482.5 (367.25–625.25) |
| Days from consent to transplantation, median (IQR) | – | 207.5 (86.75–426.75) |
| Length of hospital stay, da | 4 (25%) 5 (38%) 6 (38%) |
BMI, body mass index; ESRD, end-stage renal disease; GPA, granulomatosis with polyangiitis; HCV, hepatitis C virus; IQR, interquartile range.
a
Length of hospital stay refers to the index hospitalization for transplantation procedure.